Meet Carisma Therapeutics Inc.
Carisma Therapeutics is a biotechnology company focused on the development of macrophage-based immunotherapeutics, and the treatment of solid tumors.
The company moved into BioLabs and CIC in 2018 and raised nearly $60 million in Series A funding by summer 2019.